1996
DOI: 10.1128/jb.178.5.1242-1247.1996
|View full text |Cite
|
Sign up to set email alerts
|

Rifampin-induced initiation of chromosome replication in dnaR-deficient Escherichia coli cells

Abstract: The dnaR130 mutant of Escherichia coli, which was thermosensitive in initiation of chromosome replication, was capable of thermoresistant DNA synthesis in the presence of rifampin at a low concentration that allowed almost normal RNA synthesis. The DNA synthesis in the presence of the drug depended on protein synthesis at the high temperature. The protein synthesis in the dnaR-deficient cells provided a potential for thermoresistant DNA synthesis to be induced at a high dose of the drug that almost completely … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
3
0

Year Published

1997
1997
2013
2013

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(3 citation statements)
references
References 44 publications
(72 reference statements)
0
3
0
Order By: Relevance
“…Although PRPP is a precursor obligatory for the biosynthesis of various nucleotides, the dnaR mutant is not defective in vital functions except for the dnaA-dependent initiation of chromosome replication (Sakakibara, 1992a). The dnaR product of the prs gene seems to participate in a transcriptional event for the initiation of replication, because the dnaR defect is suppressed by certain rifampicin-resistance rpoB mutations in RNA polymerase (Sakakibara, 1995) and by rifampicin that affects the action of RNA polymerase in the initiation of replication (Sakakibara, 1996). Some of the dnaR-suppressing rpoB mutations suppress the dnaA defect in initiation of replication (Sakakibara, 1995).…”
Section: Introductionmentioning
confidence: 99%
“…Although PRPP is a precursor obligatory for the biosynthesis of various nucleotides, the dnaR mutant is not defective in vital functions except for the dnaA-dependent initiation of chromosome replication (Sakakibara, 1992a). The dnaR product of the prs gene seems to participate in a transcriptional event for the initiation of replication, because the dnaR defect is suppressed by certain rifampicin-resistance rpoB mutations in RNA polymerase (Sakakibara, 1995) and by rifampicin that affects the action of RNA polymerase in the initiation of replication (Sakakibara, 1996). Some of the dnaR-suppressing rpoB mutations suppress the dnaA defect in initiation of replication (Sakakibara, 1995).…”
Section: Introductionmentioning
confidence: 99%
“…Its further potential as a cure (26) as well as its side effects (5,17,29) are still being examined. Second, rifampicin became a tool of biochemical and genetic analysis of intracellular mechanisms of various processes (11,21,25,28). It found use in expression studies of recombinant proteins.…”
mentioning
confidence: 99%
“…Activation of DNA replication by transcription has been found in both prokaryotic (3,11,35,56,70) and eukaryotic (48, 60) cells. On the other hand, transcription has been found to suppress replication in bacterial plasmid DNA (47, 53) and in yeast (77, 82), tetrahymena (61), and human (33) cells.…”
mentioning
confidence: 99%